ESMO 2026 brings major breast cancer ADC data across HER2, TROP2, HER3, B7-H3 and Nectin-4. Here are 10 ADCs to watch in ...

Researchers in China are developing a cancer treatment that combines tiny carbon particles with iron, drawing on an idea from ...

A new review in Molecular Biology Reports maps how the apple-skin compound ursolic acid switches on cancer cell death, ...

Local Breast Cancer Screening & Care. On Oct. 21, Mesa County Public Health will host an educational event on breast health ...

Nanjing Leads Biolabs Co., Ltd. Class H ( (HK:9887) ) just unveiled an update.

A new study shows that sequencing tumor DNA in ascites, pleural fluid, cerebrospinal fluid, and pericardial effusions can ...

Oral presentation to highlight ATNM-400 antitumor activity across KRAS- and ALK-driven NSCLC models, building on earlier EGFR-mutant findings and supporting mutation-agnostic development Colorectal ...

Nanjing Leads Biolabs Co., Ltd. announced that the first patient has been dosed in an open-label, multicenter Phase Ib/II clinical trial evaluating opamtistomig (LBL-024), a PD-L1/4-1BB bispecific ...

What Research Shows About Cancer Risk and Prevention / Breast Cancer, cancer, Cancer Prevention, Cancer research, cancer risk ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the first patient has been dosed in an open-label, multicenter Phase Ib/II clinical trial ...

A 54-year-old woman found out she has ovarian cancer after persistent abdominal pain forced her to seek removal of her ...

Hold rating as VS-7375 KRAS G12D data shows promise, but dilution, competition, and cash burn persist—read now.